ANP - Antisense Therapeutics

[happytown]

nice run-up this morning (up at one stage 300%) on ann re granting of aust patent and write-up in this month's edition of "The Prostate"

aust patent - granted on the use of ATL1101 as a therapeutic agent to treat prostate cancer

[Purple XS2]

nice run-up this morning (up at one stage 300%) on ann re granting of aust patent and write-up in this month's edition of "The Prostate"

aust patent - granted on the use of ATL1101 as a therapeutic agent to treat prostate cancer

A textbook case of pump and dump - yesterday's close was 0.052, on this morning's gong after the announcement, opened at 0.080. Reached maximum price about 10:12. (0.180 - 0.200)

By 10:46 it settled back to 0.120, and it was all downhill from there, closed at 0.066.

There's been a few of these manic surges this year, particularly in small-cap biotechs.

The day-traders are adapting to rapidly changing normality. The next biotech surge will probably go through the full cycle in a matter of 10 minutes.

This is 2010 - the year of the nut.

Disclosure - not a holder. Now that the frenzy has come and gone, I might take a closer look at it.

[McCoy Pauley]

You can get a patent for a perpetual motion machine if you have a clever enough patent attorney to draft the claims (I have been told this by a former patent examiner who worked at IP Australia).

A patent by itself means very little these days - as always, it's the capacity to exploit the rights granted by the patent that would make ANP money.

[erichmj]

[Gringotts Bank]

Might be a reasonable buy at the moment. 700K traded in the first hour. Up 9%.

If 60 mill vol by end of day, maybe a .027 finish is possible.

[Superb Parrot]

Interesting, 0.23c with 55.5m shares traded.

[vercengetrix]

In accordance with ASX Listing Rule 17.1, the Directors of Antisense Therapeutics Limited
(“the Company”) request an immediate trading halt in respect of its securities (ASX Code:
ANP/ANPO).

In requesting the trading halt, the Company provides the following information:

• The trading halt is necessary as the Company expects to make an announcement to
the market in relation to a Strategic Alliance and Licensing Agreement with respect
to ATL 1102